My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 196

    1.

    Utility of casual postprandial glucose levels in type 2 diabetes management.

    El-Kebbi IM, Ziemer DC, Cook CB, Gallina DL, Barnes CS, Phillips LS.

    Diabetes Care. 2004 Feb;27(2):335-9.PMID: 14747210 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

    Harris MI; National Health and Nutrition Examination Survey (NHANES III).

    Diabetes Care. 2001 Jun;24(6):979-82.PMID: 11375356 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control.

    el-Kebbi IM, Ziemer DC, Gallina DL, Phillips LS.

    Diabetes Care. 1998 Apr;21(4):501-5.PMID: 9571331 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    5.

    Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

    Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M.

    Diabetes Care. 2001 Dec;24(12):2023-9.PMID: 11723077 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

    Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

    Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comorbidity and glycemic control in patients with type 2 diabetes.

    El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS.

    Arch Intern Med. 2001 May 28;161(10):1295-300.PMID: 11371257 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes.

    El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS.

    Arch Intern Med. 2003 Jan 13;163(1):69-75.PMID: 12523919 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    10.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

    Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y; Osaka CKD Expert Research Group.

    J Am Soc Nephrol. 2007 Mar;18(3):896-903. Epub 2007 Jan 31.PMID: 17267743 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The association between diabetes metabolic control and drug adherence in an indigent population.

    Schectman JM, Nadkarni MM, Voss JD.

    Diabetes Care. 2002 Jun;25(6):1015-21.PMID: 12032108 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.

    Clin Ther. 2007 Jan;29(1):74-83.PMID: 17379048 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hemoglobin Glycosylation Index is not related with blood glucose.

    Merino-Torres JF, Fajardo-Montañana C, Ferrer-García JC, Piñón-Sellés F.

    J Diabetes Complications. 2003 Sep-Oct;17(5):249-53.PMID: 12954152 [PubMed - indexed for MEDLINE]Related articles

    15.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    16.

    Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

    Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group.

    Diabetes Metab. 2003 Dec;29(6):587-94.PMID: 14707887 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

    Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

    Diabetes Care. 2003 Jun;26(6):1759-63.PMID: 12766106 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    19.

    The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.

    Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E.

    Diabetes Care. 2002 Oct;25(10):1840-4.PMID: 12351488 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity